{"id":137,"date":"2023-10-27T13:30:28","date_gmt":"2023-10-27T12:30:28","guid":{"rendered":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/?page_id=137"},"modified":"2026-01-26T14:11:29","modified_gmt":"2026-01-26T14:11:29","slug":"cm11","status":"publish","type":"page","link":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/research\/chemical-probes\/cm11\/","title":{"rendered":"CM11"},"content":{"rendered":"<div class=\"panel \">\n<figure class=\"wp-block-image size-large\"><source class=\"lazyload\" srcset=\"https:\/\/sites.dundee.ac.uk\/wp-content\/uploads\/sites\/233\/2023\/10\/CM11-copy.webp\" alt=\"CM11\" type=\"image\/webp\"><source class=\"lazyload\" srcset=\"https:\/\/sites.dundee.ac.uk\/wp-content\/uploads\/sites\/233\/2023\/10\/CM11-copy.jpg\" alt=\"CM11\" type=\"image\/jpeg\"><img decoding=\"async\" src=\"https:\/\/sites.dundee.ac.uk\/wp-content\/uploads\/sites\/233\/2023\/10\/CM11-copy.jpg\" alt=\"CM11\"><br \/>\n  <\/source><\/source><\/figure>\n<p class=\"media__annotation \">CM11<\/p>\n<p><strong>Protein Target(s) Name<\/strong>: E3 ubiquitin ligase VHL<\/p>\n<p><strong>Mechanism of Action<\/strong>: PROTAC degrader<\/p>\n<p><strong>Description<\/strong>: Homo-PROTAC dimerizer for self-degradation of the von Hippel-Lindau (VHL) protein. CM11 induces selective degradation of the long isoform of VHL (pVHL30) over the short isoform (pVHL19), and does so without triggering a hypoxic response in cells. CM11 also induces depletion of scaffold protein Cul2 in cells (<em>1<\/em>).<\/p>\n<p><strong>Chemical Name<\/strong>:\u00a0<em>N<\/em>1,<em>N<\/em>20-bis((<em>S<\/em>)-1-((2<em>S<\/em>,4<em>R<\/em>)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)-3,6,9,12,15,18-hexaoxaicosanediamide<\/p>\n<p><strong>CAS Number<\/strong>: 2244684-49-7<\/p>\n<p><strong>In vitro pharmacology*:<\/strong>\u00a0CM11 reduces pVHL30 protein levels in human cells: pVHL30 DC50 between 1-10 nM in HeLa cells (4 h); Dmax &gt; 99%.\u00a0CM11 induces time-dependent degradation of pVHL30, depleting 50% protein between 1-2 h of treatment at 1 uM in HeLa cells. CM11 (1 uM, 24 h) also induced 73% depletion of Cul2 in HeLa cells. Data from ref. (<em>1<\/em>)<\/p>\n<p>*DC50: concentration in molar causing 50% reduction of protein level relative to vehicle control treatment.<br \/>\nDmax: maximum reduction of protein level relative to vehicle control treatment.<\/p>\n<p><strong>Biophysical binding data<\/strong>: ITC Kd (pVHL30) = 25 nM;\u00a0ITC Kd (pVHL19) = 11 nM; stoichiometry n = 0.6 (2:1 VHL:CM11 complex); cooperativity (alpha, relative to Kd for VH032) = 18. Data from ref. (<em>1<\/em>)<\/p>\n<p><strong>Proteome-wide selectivity<\/strong>:\u00a0Unbiased and quantitative isobaric tagging MS proteomics confirmed no proteins other than VHL and Cul2 as substantially depleted upon treatment of HeLa cells with CM11 (1 uM for 10 h) amongst the 6,450 detected proteins that passed filtering criteria, compared to DMSO or VHL inhibitor VH032 treatment. Data from ref. (<em>1<\/em>)<\/p>\n<p><strong>In vivo PK data<\/strong>: not available<\/p>\n<p><strong>Crystal Structure<\/strong>: not available<\/p>\n<p><strong>Negative control<\/strong>: CMP98, CAS number: 2244684-50-0, available from\u00a0<a href=\"https:\/\/www.tocris.com\/products\/cmp-98_6417\">Tocris<\/a><\/p>\n<div><\/div>\n<p><strong>Primary References:\u00a0<\/strong><\/p>\n<ol>\n<li>Maniaci et al. (<strong>2017<\/strong>) Homo-PROTACs: Bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation.\u00a0<em>Nat. Commun.<\/em>\u00a0<em>8<\/em>, 830.\u00a0 DOI:\u00a0<a href=\"https:\/\/doi.org\/10.1038\/s41467-017-00954-1\">10.1038\/s41467-017-00954-1<\/a>; PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29018234\/\">29018234<\/a><\/li>\n<\/ol>\n<p>\u00a0<\/p>\n<p><strong>Articles that have used CM11<\/strong>:<\/p>\n<ol>\n<li>2017 Maniaci Nat Commun\u00a0<a href=\"http:\/\/dx.doi.org\/10.1038\/s41467-017-00954-1\">http:\/\/dx.doi.org\/10.1038\/s41467-017-00954-1<\/a><\/li>\n<li>2019 Steinebach Chem Commun\u00a0<a href=\"http:\/\/dx.doi.org\/10.1039\/C8CC09541H\">http:\/\/dx.doi.org\/10.1039\/C8CC09541H<\/a><\/li>\n<li>2019 Girardini Bioorg Med Chem\u00a0<a href=\"https:\/\/doi.org\/10.1016\/j.bmc.2019.02.048\">https:\/\/doi.org\/10.1016\/j.bmc.2019.02.048<\/a><\/li>\n<li>2020 Klein ACS Med Chem Lett\u00a0<a href=\"https:\/\/doi.org\/10.1021\/acsmedchemlett.0c00265\">https:\/\/doi.org\/10.1021\/acsmedchemlett.0c00265<\/a><\/li>\n<li>2021 Castro RSC Med Chem\u00a0<a href=\"https:\/\/doi.org\/10.1039\/D1MD00215E\">https:\/\/doi.org\/10.1039\/D1MD00215E<\/a><\/li>\n<li>2022 Gui ChemBioChem\u00a0<a href=\"https:\/\/doi.org\/10.1002\/cbic.202200275\">https:\/\/doi.org\/10.1002\/cbic.202200275<\/a><\/li>\n<li>2022\u00a0Trapotsi ACS Chem Biol\u00a0<a href=\"https:\/\/doi.org\/10.1021\/acschembio.2c00076\">https:\/\/doi.org\/10.1021\/acschembio.2c00076<\/a><\/li>\n<li>2023 Gui ACS Chem Biol\u00a0<a href=\"https:\/\/doi.org\/10.1021\/acschembio.3c00199\">https:\/\/doi.org\/10.1021\/acschembio.3c00199<\/a><\/li>\n<li>2023 Gui ChemBioChem\u00a0<a href=\"https:\/\/doi.org\/10.1002\/cbic.202300392\">https:\/\/doi.org\/10.1002\/cbic.202300392<\/a><\/li>\n<\/ol>\n<h2>More information<\/h2>\n<p>More information on our chemical probes can be found from the\u00a0<a href=\"http:\/\/www.chemicalprobes.org\/\">Chemical Probes portal<\/a>, and from commercial vendors such as\u00a0<a href=\"https:\/\/www.tocris.com\/\">Tocris Bio-Techne<\/a>.<\/p>\n<h3>Related links<\/h3>\n<ul>\n<li class=\"field-item even\"><a href=\"https:\/\/www.tocris.com\/products\/cm-11_6416\" target=\"_blank\" rel=\"noopener\">Tocris Biotechne: CM 11 Cat. No. 6416<\/a><\/li>\n<li class=\"field-item odd\"><a href=\"https:\/\/www.tocris.com\/products\/cmp-98_6417\" target=\"_blank\" rel=\"noopener\">Tocris Biotechne: CMP 98 Cat. No. 6417<\/a><\/li>\n<li class=\"field-item even\"><a href=\"https:\/\/www.chemicalprobes.org\/cm11\" target=\"_blank\" rel=\"noopener\">Chemical Probes.org: CM11<\/a><\/li>\n<li class=\"field-item odd\"><a href=\"https:\/\/www.medchemexpress.com\/Homo-PROTAC_pVHL30_degrader_1.html\" target=\"_blank\" rel=\"noopener\">MedChemExpress: CM11 Cat. No. HY-111593<\/a><\/li>\n<li class=\"field-item even\"><a href=\"https:\/\/www.invivochem.com\/cm11.html\" target=\"_blank\" rel=\"noopener\">InvivoChem: CM11 Cat #: V17301<\/a><\/li>\n<li class=\"field-item odd\"><a href=\"http:\/\/www.dcchemicals.com\/product_show-DC11590.html\" target=\"_blank\" rel=\"noopener\">DC chemicals: CM11 Cat. No.: DC11590<\/a><\/li>\n<li class=\"field-item even\"><a href=\"https:\/\/www.targetmol.com\/compound\/Homo-PROTAC%20pVHL30%20degrader%201\" target=\"_blank\" rel=\"noopener\">TargetMol: Homo-PROTAC pVHL30 degrader 1 Catalog No. T13722<\/a><\/li>\n<li class=\"field-item odd\"><a href=\"https:\/\/protac.bocsci.com\/product\/cm-11-285267.html?nid=3051\" target=\"_blank\" rel=\"noopener\">Boc Sciences PROTAC: CM 11<\/a><\/li>\n<li class=\"field-item even\"><a href=\"https:\/\/protac.bocsci.com\/product\/cmp-98-285273.html?nid=3051\" target=\"_blank\" rel=\"noopener\">Boc Sciences PROTAC: CMP 98<\/a><\/li>\n<li class=\"field-item odd\"><a href=\"http:\/\/www.probechem.com\/products_CM11.aspx\" target=\"_blank\" rel=\"noopener\">ProbeChem: CM11 Catalog No.: PC-60127<\/a><\/li>\n<li class=\"field-item even\"><a href=\"https:\/\/www.amadischem.com\/proen\/613159\/\" target=\"_blank\" rel=\"noopener\">Amadis Chemical: Homo-PROTAC pVHL30 degrader 1<\/a><\/li>\n<li class=\"field-item odd\"><a href=\"https:\/\/www.chemicalprobes.org\/news\/2020s-top-probes\" target=\"_blank\" rel=\"noopener\">2020s Top Probes | Chemical Probes<\/a><\/li>\n<\/ul>\n<p>\u00a0<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CM11 Protein Target(s) Name: E3 ubiquitin ligase VHL Mechanism of Action: PROTAC degrader Description: Homo-PROTAC dimerizer for self-degradation of the von Hippel-Lindau (VHL) protein. CM11 induces selective degradation of the long isoform of VHL (pVHL30) over the short isoform (pVHL19), and does so without triggering a hypoxic response in cells. CM11 also induces depletion of [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":105,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-137","page","type-page","status-publish","hentry"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/wp-json\/wp\/v2\/pages\/137","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/wp-json\/wp\/v2\/comments?post=137"}],"version-history":[{"count":2,"href":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/wp-json\/wp\/v2\/pages\/137\/revisions"}],"predecessor-version":[{"id":4406,"href":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/wp-json\/wp\/v2\/pages\/137\/revisions\/4406"}],"up":[{"embeddable":true,"href":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/wp-json\/wp\/v2\/pages\/105"}],"wp:attachment":[{"href":"https:\/\/sites.dundee.ac.uk\/alessio-ciulli\/wp-json\/wp\/v2\/media?parent=137"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}